US EditionActio Advancing Genetics-Driven Pipeline
Summary by San Diego Business Journal
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Actio Advancing Genetics-Driven Pipeline
SAN DIEGO – Investors delivered another $66 million backing drug discovery advances from Actio Biosciences – advances that its leadership says show therapeutic hope combatting a potentially fatal form of epilepsy and other diseases both rare and common. Actio, a clinical-stage biotech based in Sorrento Valley, announced closing last week on Series B financing for […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
